These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18792090)

  • 1. Childhood cancer: quest for a complete cure.
    Kellie SJ; Al-Lamki Z; Agarwal BR; Wali Y; Ngcamu N; Al-Sawafi N; Kurkure P
    Pediatr Blood Cancer; 2008 Dec; 51(6):843-5. PubMed ID: 18792090
    [No Abstract]   [Full Text] [Related]  

  • 2. What changes are needed to the current direction and interpretation of clinical cancer research to meet the needs of the 21st century? Comment.
    Gandhi MK
    Med J Aust; 2009 Apr; 190(8):461; author reply 461. PubMed ID: 19374627
    [No Abstract]   [Full Text] [Related]  

  • 3. Why event-free survival is better than tumor response or other measures of survival as an endpoint in cancer trials.
    Dillman RO
    Cancer Biother Radiopharm; 1996 Apr; 11(2):99-104. PubMed ID: 10851525
    [No Abstract]   [Full Text] [Related]  

  • 4. Research involving long-term survivors of childhood and adolescent cancer: issues impacting design and conduct of clinical trials.
    Murphy SB
    Curr Probl Cancer; 2003; 27(4):225-35. PubMed ID: 12855953
    [No Abstract]   [Full Text] [Related]  

  • 5. Proposal for the use of progression-free survival in unblinded randomized trials.
    Freidlin B; Korn EL; Hunsberger S; Gray R; Saxman S; Zujewski JA
    J Clin Oncol; 2007 May; 25(15):2122-6. PubMed ID: 17513819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surviving childhood cancer: a special series on the successes and challenges after "cure".
    Arceci RJ
    Pediatr Blood Cancer; 2006 Feb; 46(2):119-21. PubMed ID: 16320314
    [No Abstract]   [Full Text] [Related]  

  • 7. Effective childhood cancer treatment: the impact of large scale clinical trials in Germany and Austria.
    Rossig C; Juergens H; Schrappe M; Moericke A; Henze G; von Stackelberg A; Reinhardt D; Burkhardt B; Woessmann W; Zimmermann M; Gadner H; Mann G; Schellong G; Mauz-Koerholz C; Dirksen U; Bielack S; Berthold F; Graf N; Rutkowski S; Calaminus G; Kaatsch P; Creutzig U
    Pediatr Blood Cancer; 2013 Oct; 60(10):1574-81. PubMed ID: 23737479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restricted Mean Survival Time: An Obligatory End Point for Time-to-Event Analysis in Cancer Trials?
    A'Hern RP
    J Clin Oncol; 2016 Oct; 34(28):3474-6. PubMed ID: 27507871
    [No Abstract]   [Full Text] [Related]  

  • 9. Survival of patients with cancer.
    Coltart S
    BMJ; 1989 Dec; 299(6712):1403. PubMed ID: 2513986
    [No Abstract]   [Full Text] [Related]  

  • 10. [Methodology of clinical trials].
    Quantin X; Jacot W; Choma D; Pujol JL
    Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S13-6. PubMed ID: 11924235
    [No Abstract]   [Full Text] [Related]  

  • 11. Survival of patients with cancer.
    Stiller CA
    BMJ; 1989 Oct; 299(6707):1058-9. PubMed ID: 2511962
    [No Abstract]   [Full Text] [Related]  

  • 12. [Some proposals to cancer clinical trials in Japan--a biostatistician's view].
    Oh-hashi Y
    Gan To Kagaku Ryoho; 1993 Dec; 20(16):2483-95. PubMed ID: 8279846
    [No Abstract]   [Full Text] [Related]  

  • 13. Long term survivors of childhood cancer: cure and care. The Erice statement.
    Haupt R; Spinetta JJ; Ban I; Barr RD; Beck JD; Byrne J; Calaminus G; Coenen E; Chesler M; D'Angio GJ; Eiser C; Feldges A; Gibson F; Lackner H; Masera G; Massimo L; Magyarosy E; Otten J; Reaman G; Valsecchi MG; Veerman AJ; Penn A; Thorvildsen A; van den Bos C; Jankovic M;
    Eur J Cancer; 2007 Aug; 43(12):1778-80. PubMed ID: 17543517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of autologous transplantation in the treatment of malignant disorders.
    Territo M
    J Rheumatol Suppl; 1997 May; 48():36-40. PubMed ID: 9150116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cure of cancer for seven cancer sites in the Flemish Region.
    Silversmit G; Jegou D; Vaes E; Van Hoof E; Goetghebeur E; Van Eycken L
    Int J Cancer; 2017 Mar; 140(5):1102-1110. PubMed ID: 27870056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival and Participation in a Cancer Clinical Trial: A Provocative Relationship.
    Markman M
    Oncology; 2016; 91(4):177-178. PubMed ID: 27560780
    [No Abstract]   [Full Text] [Related]  

  • 17. Endpoints in cancer clinical trials.
    Fiteni F; Westeel V; Pivot X; Borg C; Vernerey D; Bonnetain F
    J Visc Surg; 2014 Feb; 151(1):17-22. PubMed ID: 24440056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical use of multimodality therapy in the management of cancer.
    Raben D; Williams J; Abrams RA
    In Vivo; 1994; 8(5):635-42. PubMed ID: 7727710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Report from the colloquium on long-term clinical trial strategies].
    Sakamoto J; Nakazato H
    Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 1):701-8. PubMed ID: 2138874
    [No Abstract]   [Full Text] [Related]  

  • 20. DC-based cancer vaccines: lessons from clinical trials.
    Brody JD; Engleman EG
    Cytotherapy; 2004; 6(2):122-7. PubMed ID: 15203988
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.